Value of N-terminal pro-B-type natriuretic peptide on long-term outcome of patients with hypertrophic cardiomyopathy
10.3760/cma.j.issn.0253-3758.2018.03.005
- VernacularTitle: 血N末端B型利钠肽原升高对肥厚型心肌病患者远期预后的影响
- Author:
Xiangbin MENG
1
;
Wenyao WANG
;
Kuo ZHANG
;
Yu QI
;
Shimin AN
;
Siyuan WANG
;
Jilin ZHENG
;
Qinjun YU
;
Bing TANG
;
Rong WU
;
Shuiyun WANG
;
Chuanyu GAO
;
Yida TANG
Author Information
1. Department of Cardiology, Coronary Heart Disease Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
- Publication Type:Clinical Trail
- Keywords:
Cardiomyopathy, hypertrophic;
Prognosis;
Mortality;
Heart transplantation;
N-terminal pro-B-type natriuretic peptide
- From:
Chinese Journal of Cardiology
2018;46(3):192-197
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To determine the value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) on predicting the long-term outcome of patients with hypertrophic cardiomyopathy (HCM) .
Methods:NT-proBNP was measured in 831 consecutive patients with HCM at Fuwai Hospital from October 2009 to December 2013 and patients were followed up clinically for (53.3±15.4) months. Patients were divided into 3 groups according to NT-proBNP values: NT-proBNP<860 pmol/L (n=276) , 860 pmol/L≤NT-proBNP≤1 905 pmol/L (n=278) , NT-proBNP>1 905 pmol/L (n=277) . The related baseline data, laboratory examination and echocardiographic results were compared among groups. The primary endpoints of this study were all-cause mortality and cardiac transplantation. Cox proportional hazards model was used to estimate hazard ratio (HR) . Kaplan-Meier analysis was used to evaluate the survival status of patients among the 3 groups.
Results:During a median follow-up of (53.3±15.4) months, all-cause mortality or cardiac transplantation occurred in 37 patients (4.5%) , event rate was 1.4% (4/276) , 4.0% (11/278) and 7.9% (22/277) in patients with NT-proBNP<860 pmol/L, 860 pmol/L≤NT-proBNP≤1 905 pmol/L and NT-proBNP>1 905 pmol/L, respectively. Multivariable Cox regression analysis identified that age (HR 1.066, 95%CI 1.027-1.107) and NT-proBNP (HR 1.026, 95% CI 1.010-1.042) were independent predictors of all-cause mortality or cardiac transplantation. Among the 3 groups, the survival rate of the NT-proBNP<860 pmol/L group was the highest,and that of the NT-proBNP>1 905 pmol/L group was the lowest (P<0.01) .
Conclusions:The level of NT-proBNP provides clinically relevant information for long-term adverse events risk stratification in patients with HCM.